PharVision Advisers’s First American FAF Stock Holding History

PharVision Advisers’s Portfolio FAF Stock Details FAF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,755	Closed	-$231K	–	291
2025 Q4	$231K	Buy	+3,755	New	+$235K	0.12%	443

Other funds holding FAF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

PharVision Advisers's FAF Position: Q1 2026 in Review

PharVision Advisers sold out of First American (FAF) in Q1 2026, closing a stake of 3,755 shares — an estimated $231K sold.

PharVision Advisers first reported a position in FAF in Q4 2025 and held it in 1 quarter. The position peaked at $231K in Q4 2025. 435 funds tracked by Wall St. Rank hold FAF as of Q1 2026.

PharVision Advisers reported no remaining First American position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 3,755 First American shares in Q1 2026, an estimated $231K.
PharVision Advisers first reported a position in First American in Q4 2025 and held it in 1 quarter.
PharVision Advisers's First American position peaked at $231K in Q4 2025.
435 funds tracked by Wall St. Rank held First American as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.